Findings
========

NK cells are cytotoxic cells of the innate immune system, which contribute to the control of many virus infections. They express a variety of different receptors on their surface driving their functions towards activating or inhibitory responses. NK cells mediate their effector functions through recognition and elimination of virus-infected cells. However, for several viral infections it was shown that NK cells suppress the adaptive immunity by killing virus--specific T cells \[[@B1]-[@B4]\]. This resulted in increased viral loads and might contribute to impaired viral clearance. On the other hand it has been demonstrated that HIV uses different mechanisms to escape NK cell responses. HIV modulates the ligand expression of the activating NK cell receptor NKG2D on infected cells resulting in reduced NK cell activation \[[@B5]\]. Additionally, mutational adaptation of HIV has been shown to result in stimulation of inhibitory receptors on NK cells and subsequent escape from NK cell-mediated immune pressure \[[@B6]\]. These opposed mechanisms suggest that NK cells may have distinct effects in different phases of viral infections. Here we analyzed these effects in the murine Friend retrovirus (FV) model by depletion of NK cells at different time points after retroviral infection. The antiviral role of NK cells during an acute FV infection has been investigated in several previous studies. However, almost all of these studies were performed with FV stocks containing Lactate dehydrogenase elevating virus (LDV). Only one recent paper with LDV-free FV showed that NK cells recognize infected target cells by interaction of RAE-1 and NKG2D \[[@B7]\]. LDV induces a massive type I interferon response during acute infection, which we have shown to significantly modulate NK cell responses \[[@B8]\]. Since LDV-free FV induces only barely detectable levels of type I interferons, the previous studies provide very little useful information on the role of NK cells in the immune control of FV infection. We therefore addressed this question in mice that were infected with a LDV-free FV stock.

Kinetics of FV infection in different lymphoid organs
-----------------------------------------------------

To characterize the effector functions of NK cells during different phases of FV infection, we first analyzed the kinetics of virus infection in CB6F1 mice, a cross of highly susceptible Balb/c mice and resistant C57BL/6 mice. FV infection resulted in the development of a severe splenomegaly starting at day 9 post infection (dpi) demonstrating their FV susceptibility (Figure  [1](#F1){ref-type="fig"}A). Spleen weights peaked 15 dpi with a significant higher mean weight (3.36 g) compared to naive control mice (0.12 g) and afterwards steadily declined. The kinetics of acute viral loads in spleen and bone marrow of infected mice are shown in Figure  [1](#F1){ref-type="fig"}B. These organs were known to be the main reservoir for FV replication \[[@B9]\]. During initial FV infection, virus-infected cells were detected as early as 3 dpi in the bone marrow and 4 dpi in the spleen, the viral loads peaked 7 and 9 dpi, respectively. Subsequently, the viral loads constantly declined until 30 dpi.

![**Kinetics of FV infection.** Spleen weights of FV-infected CB6F1 mice were determined at different time points after FV infection **(A)**. Statistically significant differences compared to naive mice (0 dpi) are indicated by \* for p \< 0.05; \*\* for p \< 0.01; \*\*\* for p \< 0.001. Viral loads of FV-infected CB6F1 mice were analyzed in bone marrow and spleen using an infectious center assay **(B)**. At least six mice per group were analyzed and the mean values for each group are indicated by a symbol + SEM.](1742-4690-10-127-1){#F1}

To analyze the impact of NK cells on FV replication, we depleted NK cells during different phases of infection. Here, we focused on three different time points of acute FV infection. 1) The initial phase (3--4 dpi), when only NK cells are able to kill virus-infected cells because T cell responses are not yet developed \[[@B9]\]. 2) At the peak of virus replication (7--15 dpi), when virus-specific T cells are detectable and eliminate infected target cells \[[@B9]\]. 3) The late phase (30 dpi), when viral loads are reduced but FV-induced leukemia starts to develop. Then cytotoxic CD8^+^ T cells become dysfunctional in FV infection \[[@B9]\].

Anti-retroviral effects of NK cells during initial FV infection
---------------------------------------------------------------

As *in vivo* depletion with antibodies against NK1.1 has the potential to affect other cell subsets, we analyzed their influence on NKT cells. Figure  [2](#F2){ref-type="fig"}C and [2](#F2){ref-type="fig"}D illustrate an up to 70% depletion of NKT cells by application of α-NK1.1 in spleen and bone marrow of FV-infected mice. Thus, both cell subsets, NK and NKT cells, might influence anti-retroviral immunity. Figure  [2](#F2){ref-type="fig"}A and [2](#F2){ref-type="fig"}B indicate that ablation of NK and NKT cells in the initial phase of FV infection (3--4 dpi) resulted in a significant increase in viral loads compared to non-depleted control mice, which was determined by infectious center (IC) assay (for detailed description of experimental procedures, see Additional file  [1](#S1){ref-type="supplementary-material"}) and RT-PCR analysis (data not shown). In the bone marrow (Figure  [2](#F2){ref-type="fig"}A) an 8.5-fold increase in viral loads was observed at 3 dpi. In the spleen (Figure  [2](#F2){ref-type="fig"}B) 5-fold to 15-fold elevated viral loads were detected at 4 and 3 dpi, respectively. At this early time point of infection no significant activation of NK and NKT cells, indicated by the expression of CD69, was found (Figure  [3](#F3){ref-type="fig"}A, [3](#F3){ref-type="fig"}B and data not shown). However, functional activation of NK cells, but not NKT cells (data not shown), were observed, reflected by a significant increase in tumor necrosis factor related apoptosis inducing ligand (TRAIL) and granzyme B expression (Figure  [3](#F3){ref-type="fig"}C and [3](#F3){ref-type="fig"}E) in the bone marrow of FV-infected mice. In splenic NK cells increased levels of *perforin* mRNA were detected at 4 dpi (Figure  [3](#F3){ref-type="fig"}H) compared to naive controls. The effector function of NK cells during the initial infection was confirmed in an *in vitro* cytotoxicity assay. Increased killing of target cells (YAC-1) was mediated by NK cells from spleen or bone marrow of FV-infected mice (Figure  [3](#F3){ref-type="fig"}F and [3](#F3){ref-type="fig"}G). Altogether, during the initial phase of FV infection, when T cell responses are not yet developed, NK cells or NKT cells mediate early protective anti-retroviral immunity.

![**Viral loads in NK cell depleted FV-infected mice.** Mice were infected with FV and NK cells were depleted by injecting cell culture supernatant containing α-NK1.1 antibody or isotype control (BioXCell). Viral loads were determined in the bone marrow **(A)** and spleen **(B)** by infectious center assay at different phases of infection. A minimum of four mice per group were analyzed and the mean values are indicated by bars + SEM. Experiments were repeated at least twice. Bone marrow cells **(C)** and splenocytes **(D)** were analyzed by flow cytometry in order to distinguish NK cells (CD3^-^ CD49b^+^ NK1.1^+^) and NKT cells (CD3^+^ NK1.1^+^). NK cells were depleted with an efficiency of at least 95%, whereas up to 70% of total NKT cells were ablated. A minimum of seven mice per group were used. Experiments were repeated at least twice. Total numbers of individual cell types per 10^6^ lymphocytes were calculated and indicated by bars + SEM. Statistically significant differences between depleted FV-infected mice and non-depleted FV-infected mice are indicated by \* for p \< 0.05 and \*\*\* for p \< 0.001.](1742-4690-10-127-2){#F2}

![**Activation and effector functions of NK cells.** Bone marrow cells and splenocytes of FV-infected or naive (0 dpi) CB6F1 mice were analyzed by flow cytometry at different time points **(A-E)**. The early activation marker CD69 was used to determine the percentage of activated NK cells (CD3^-^ CD49b^+^ NK1.1^+^ CD69^+^; **A-B**). At least eight mice of minimum two independent experiments were used and the mean values are shown by bars + SEM. The effector functions of NK cells were determined measuring the intracellular expression of granzyme B **(C)**, IFN-γ **(D)** and the surface expression of TRAIL **(E)**. A minimum of seven mice in at least two independent experiments were analyzed. The cytotoxic potential of NK cells in the bone marrow and spleen was analyzed in an *in vitro* NK cell cytotoxicity assay. NK cells were isolated from spleen and bone marrow of FV-infected mice at different time points during infection (3--4 dpi, 15 dpi and 30 dpi) **(F-G)**. MHC-I-negative target cells (YAC-1) were stained with CFSE and co-cultured with isolated NK cells at effector-target ratio of 25:1 for 24 h. At least four mice were used for the analysis. **(H)** Levels of *perforin* mRNA were measured in splenocytes at day 3--4 post FV infection by quantitative real time-PCR. The housekeeping gene β-actin was amplified from each sample to normalize the template concentration and used as an internal standard. At least 2 independent experiments with four mice were performed and the samples were run in duplicate. Statistically significant differences between the groups of infected mice and naive mice are indicated by \* for p \< 0.05; \*\* for p \< 0.01; \*\*\* for p \< 0.001.](1742-4690-10-127-3){#F3}

No effect of NK cells during the peak FV replication
----------------------------------------------------

Next, we examined the function of NK cells 7--15 dpi, when T cells expand and control FV replication \[[@B9],[@B10]\]. Depletion of NK and NKT cells during this phase of infection did not influence viral loads in both investigated organs, which was shown by an IC assay (Figure  [2](#F2){ref-type="fig"}A- [2](#F2){ref-type="fig"}B) and RT-PCR analysis (data not shown). However, at that time point both cell subsets started to express high levels of CD69 (Figure  [3](#F3){ref-type="fig"}A, [3](#F3){ref-type="fig"}B and data not shown). The expression of the functional molecules granzyme B, interferon-γ (IFN), or TRAIL were elevated only in NK cells from spleen or bone marrow (Figure  [3](#F3){ref-type="fig"}C- [3](#F3){ref-type="fig"}E), but isolated NK cells failed to eliminate target cells (Figure  [3](#F3){ref-type="fig"}F and [3](#F3){ref-type="fig"}G) which correlated with the findings from the depletion experiments (Figure  [2](#F2){ref-type="fig"}A- [2](#F2){ref-type="fig"}B). Thus at 7 to 15 dpi NK cells and NKT cells did not contribute to antiviral immunity, which is mainly mediated by CD8^+^ T cells during peak viral replication \[[@B9]\].

Negative effects of NK cells during the late phase of acute FV infection
------------------------------------------------------------------------

During the late phase of FV infection (30 dpi) susceptible mice start to develop a lethal erythroleukemia. Then virus-infected as well as transformed cells are potential targets for NK cells. To evaluate their role during this phase, we performed depletion experiments starting at 20 dpi. Surprisingly, application of α-NK1.1 antibody resulted in a significant reduction of viral loads at 30 dpi, which was observed by an IC assay (Figure  [2](#F2){ref-type="fig"}A- [2](#F2){ref-type="fig"}B) and RT-PCR analysis (data not shown). An 8-fold decrease of the viral loads in the bone marrow (Figure  [2](#F2){ref-type="fig"}A) and a 4-fold reduction in the spleen (Figure  [2](#F2){ref-type="fig"}B) was observed compared to control mice. NK cells were still activated (CD69^+^) at this late time point (Figure  [3](#F3){ref-type="fig"}A and [3](#F3){ref-type="fig"}B) and expressed elevated levels of granzyme B (Figure  [3](#F3){ref-type="fig"}C) and IFN-γ (Figure  [3](#F3){ref-type="fig"}D). TRAIL was not detected on NK cells from mice infected for 30 days (Figure  [3](#F3){ref-type="fig"}E). Next, we analyzed if up-regulation of effector molecules correlated with the cytotoxic potential of NK cells during late acute FV infection. Figure  [3](#F3){ref-type="fig"}F and [3](#F3){ref-type="fig"}G show that NK cells isolated 30 dpi significantly lysed target cells. 30 dpi NK cells were activated and had an effector phenotype, which allowed them to specifically kill target cells *in vitro*. Surprisingly, NK and NKT cells did not contribute to viral immunity but rather negatively influenced viral loads during the late phase of acute FV infection.

NK cell depletion improved specific CD8^+^ T cell responses in FV-infected mice
-------------------------------------------------------------------------------

The depletion experiments revealed that the presence of NK or NKT cells during the late phase of acute FV infection enhanced viral loads. We addressed the question, if these cells impair virus-specific T cell responses. Therefore, mice with or without NK cells and NKT cells were analyzed for their virus-specific T cell responses 30 dpi. Depletion with α-NK1.1 antibody had no significant effect on the percentages of virus-specific CD4^+^ T cells (Figure  [4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B). Whereas the depletion significantly increased the frequency and numbers of virus-specific CD8^+^ T cells in both investigated organs without changing the total numbers of CD8^+^ T cells (Figure  [4](#F4){ref-type="fig"}C-- [4](#F4){ref-type="fig"}H). Further analysis of the functionality of effector CD8^+^ T cells revealed a significant higher amount of CD8^+^ T cells producing IFN-γ in the bone marrow of depleted mice (Figure  [4](#F4){ref-type="fig"}I). These data imply that activated NK cells suppress CD8^+^ T cell responses and impair anti-retroviral immunity during the late phase of acute FV infection.

![**FV-specific CD4**^**+**^**and CD8**^**+**^**T cell responses in the absence of NK cells.** CB6F1 mice were infected with FV and one group of mice was NK cell depleted. Bone marrow and spleen cells were analyzed at 30 dpi. For the analysis of activated (CD43^+^ CD44^+^) virus-specific CD4^+^ T cells, bone marrow **(A)** and splenic **(B)** cells were stained with MHC class II-antibody tetramers specific for F-MuLV env fn20 \[[@B11]\]. Numbers of total CD8^+^ T cells were analyzed by flow cytometry in bone marrow **(C)** and spleen **(D)**. Numbers **(E, F)** and percentages **(G, H)** of activated (CD43^+^ CD62L^-^) effector CD8^+^ T cells, which are specific for the FV gagL epitope, were stained for D^b^gagL class I tetramers and determined by flow cytometry in bone marrow **(E, G)** and spleen **(F, H)**. Bone marrow **(I)** and splenic **(J)** activated CD8^+^ T cells were stained intracellularly for IFN-γ. A minimum of seven mice were used for analysis. At least two independent experiments were performed. Significant differences between the groups were analyzed by using the unpaired Students t test (\*\* for p \< 0.01) statistically significant by an unpaired t test (\*\* for p \< 0.01).](1742-4690-10-127-4){#F4}

In this report, we analyzed NK cell effector functions and their impact on viral replication and adaptive immune responses during acute retroviral infection. Altogether, we identified an antiviral role of NK cells or NKT cells during the initial FV infection (3--4 dpi), which might contribute to the early control of viral replication. Others could already show that mice deficient in NKT cells were more susceptible in controlling some viruses like HSV-1/2, MCMV, and EMCV (reviewed in \[[@B12]\]). Thus, either NK cells or NKT cells might participate in the early antiviral immunity against FV. Later during infection, CD8^+^ T cells become the key players of anti-retroviral immunity \[[@B9]\] and replace NK and NKT cell responses. However, the strong CD8^+^ T cell responses might have to be counter-regulated in some virus infections to prevent immunopathology. There is growing evidence that NK cells and not NKT cells play a role in this regulation. In the LCMV-model, it was shown that depletion of NK cells alone enhanced T cell responses and thus mice could control viral replication and thereby prevent chronic infection \[[@B2]\]. The NK cell-mediated inhibition of CD8^+^ T cells in this model depended on NKG2D binding and perforin production. Others reported that activated NK cells eliminate CD4^+^ T cells in a perforin-dependent manner, which might indirectly affect CD8^+^ T cell function and exhaustion during LCMV infection \[[@B1]\]. We did not observe an effect of NK cell depletion on CD4^+^ T cell responses suggesting a direct suppressive effect of NK cells on CD8^+^ T cells in our model. Others demonstrated that NK cell depletion during high-dose influenza infection improved the survival rate of infected mice which was not seen in medium- or low-dose influenza infections \[[@B3],[@B13],[@B14]\]. The data indicate that viral loads might predict the effector functions of NK cells. Moreover, during herpes virus infection, a regulatory role of NK cells was described. It was shown that a strong NK cell response can limit T cell responses in MCMV infection \[[@B15],[@B16]\]. Altogether, it seems that the balance of NK and T cell responses seems to be critical for viral immunity and the impact of NK cells depends on the type and dose of virus as well as the phase of virus infection. Thus, it is very important to further investigate the factors that influence NK cell regulatory functions.
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